nVector
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Medical device or technology
- Diagnostics
nVector provides cutting edge CNS based gene therapies, designer AAV capsids to target specific cell types, clinical grade biomarker assays, and the development of new biomarker assays to accelerate your existing projects and quick-launch new initiatives. Our patented GreenGlia Technology enables us to access cells never before targeted, such as microglia, the brain immune cells, and neurons by cell type. The nVector offering includes both fully formed solutions, and the capability to customize to your unique specifications.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}